MirZyme Therapeutics
PrivateLast Round
Series A
Apr 21, 2025
Total Funding Raised
$910,000
Company Overview
MirZyme Therapeutics is a biopharmaceutical company that develops laboratory-based diagnostic assays and orally administered therapeutic compounds to prevent preeclampsia and fetal growth restriction.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MirZyme Therapeutics Comparables
Compare MirZyme Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Comanche Biopharma | 86% | |
| Trinity Biotech plc | 77% | |
| Corion Biotech | 76% |
MirZyme Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 21, 2025 | ||||
| Accelerator | Aug 21, 2024 | ||||
| Grant | May 1, 2024 | ||||
| Grant | Nov 1, 2023 |
Key People
Founding team and executive leadership
MirZyme Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 25, 2026
Monthly visitors grew 136% MoM.
- Oct 30, 2024
Monthly visitors increased 60% MoM.
MirZyme Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about MirZyme Therapeutics's valuation, stock price, and market status.
Is MirZyme Therapeutics a public or private company?
MirZyme Therapeutics is a private company.
What is the current stock price of MirZyme Therapeutics?
MirZyme Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is MirZyme Therapeutics worth (valuation)?
Valuation information for MirZyme Therapeutics is not publicly available.
Can I buy MirZyme Therapeutics stock?
MirZyme Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was MirZyme Therapeutics's last funding round?
MirZyme Therapeutics's most recent funding round was Series A on April 21, 2025.
Who are the main investors in MirZyme Therapeutics?
Key investors in MirZyme Therapeutics include Innovate UK.
Will MirZyme Therapeutics IPO soon?
No public IPO plans have been announced for MirZyme Therapeutics.
How can I track MirZyme Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MirZyme Therapeutics's secondary market activity and sign up for updates.